[go: up one dir, main page]

BR9608898A - Processo para à melhora de respostas imunes protetoras - Google Patents

Processo para à melhora de respostas imunes protetoras

Info

Publication number
BR9608898A
BR9608898A BR9608898A BR9608898A BR9608898A BR 9608898 A BR9608898 A BR 9608898A BR 9608898 A BR9608898 A BR 9608898A BR 9608898 A BR9608898 A BR 9608898A BR 9608898 A BR9608898 A BR 9608898A
Authority
BR
Brazil
Prior art keywords
immune responses
protective immune
improving protective
improving
responses
Prior art date
Application number
BR9608898A
Other languages
English (en)
Inventor
Steven G Reed
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/607,509 external-priority patent/US5876735A/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9608898A publication Critical patent/BR9608898A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9608898A 1995-06-06 1996-06-05 Processo para à melhora de respostas imunes protetoras BR9608898A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48838695A 1995-06-06 1995-06-06
US08/607,509 US5876735A (en) 1994-04-22 1996-02-23 Methods for enhancement of protective immune responses
US08/634,642 US5879687A (en) 1994-04-22 1996-04-18 Methods for enhancement of protective immune responses
PCT/US1996/009141 WO1996039524A1 (en) 1995-06-06 1996-06-05 Methods for enhancement of protective immune responses

Publications (1)

Publication Number Publication Date
BR9608898A true BR9608898A (pt) 1999-06-29

Family

ID=27413802

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608898A BR9608898A (pt) 1995-06-06 1996-06-05 Processo para à melhora de respostas imunes protetoras

Country Status (11)

Country Link
US (1) US5879687A (pt)
EP (1) EP0832236A1 (pt)
JP (1) JP2001503014A (pt)
KR (1) KR19990022654A (pt)
CN (1) CN1194000A (pt)
AU (1) AU5988096A (pt)
BR (1) BR9608898A (pt)
CA (1) CA2223421A1 (pt)
NO (1) NO975730L (pt)
NZ (1) NZ309659A (pt)
WO (1) WO1996039524A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE199316T1 (de) * 1993-12-23 2001-03-15 Bruno Gander Mit antigen beladene mikropartikel und pharmazeutische zubereitungen, die diese mikropartikel enthalten.
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) * 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5834592A (en) * 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
DK1584685T3 (da) * 1998-02-05 2011-07-11 Glaxosmithkline Biolog Sa Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
US20050158856A1 (en) * 1999-04-20 2005-07-21 Edelson Richard L. Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
FR2862313B1 (fr) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
EP3072522B1 (en) 2005-01-06 2019-04-24 Novo Nordisk A/S Anti-kir combination treatments and methods
WO2006099875A1 (en) 2005-03-23 2006-09-28 Genmab A/S Antibodies against cd38 for treatment of multiple myeloma
US7833534B2 (en) 2006-04-10 2010-11-16 Infectious Disease Research Institute Compounds and methods for diagnosis and treatment of leishmaniasis
MX2009002195A (es) 2006-08-30 2009-05-28 David William Smith Metodo para impartir una rigidez mono-axial o multi-axial a materiales extruidos y productos que resultan de los mismos.
ES2628743T3 (es) 2008-07-03 2017-08-03 Infectious Disease Research Institute Proteínas de fusión y su uso en el diagnóstico y tratamiento de la leishmaniasis
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
WO2010088393A2 (en) * 2009-01-28 2010-08-05 Antigen Express, Inc. Li-kay hybrid peptides that modulate the immune response to influenza
US9545421B2 (en) 2010-05-04 2017-01-17 General Electric Company Nucleic acid delivery vehicle and uses thereof
PL2580243T3 (pl) 2010-06-09 2020-05-18 Genmab A/S Przeciwciała przeciwko ludzkiemu CD38
PL2582728T3 (pl) 2010-06-15 2018-01-31 Genmab As Koniugaty ludzkie przeciwciało-lek przeciwko czynnikowi tkankowemu
CN111154807B (zh) * 2020-01-17 2023-03-24 山东农业大学 一种分泌型的崂山奶山羊乳腺上皮细胞系的构建方法
DE102022131277A1 (de) 2022-11-25 2024-05-29 Schwäbische Hüttenwerke Automotive GmbH Pumpe-Motor-Einheit mit integrierter Kühlung einer Elektronikkomponente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
US5543143A (en) * 1992-03-06 1996-08-06 Corixa Corporation Method for activating macrophages/monocytes
AU695273B2 (en) * 1994-04-22 1998-08-13 Corixa Corporation Compounds and methods for the stimulation and enhancement ofprotective immune responses and IL-12 production
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses

Also Published As

Publication number Publication date
WO1996039524A1 (en) 1996-12-12
NZ309659A (en) 2000-01-28
KR19990022654A (ko) 1999-03-25
EP0832236A1 (en) 1998-04-01
CN1194000A (zh) 1998-09-23
AU5988096A (en) 1996-12-24
US5879687A (en) 1999-03-09
NO975730L (no) 1998-02-05
MX9709737A (es) 1998-10-31
JP2001503014A (ja) 2001-03-06
NO975730D0 (no) 1997-12-05
CA2223421A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
BR9608898A (pt) Processo para à melhora de respostas imunes protetoras
PT770615E (pt) Processo para a preparacao de di-haloazolopirimidinas
BR9606782A (pt) Processo para preparar ciclopilacetileno
BR9306679A (pt) Processo para obtenção de lecitina
BR9701330A (pt) Processo e aparelho para refinamento de silício
ITMI932443A0 (it) Processo per preparare perfluoropolietri
BR9105129A (pt) Processo e aparelho para pirolise de hidrocarbonetos
BR9203594A (pt) Processo e aparelho para obtencao de confeito gaseificado e conteito
BR9601233A (pt) Processo de fabricação de dispositivos evidenciadores de transação
BR9300739A (pt) Processo hidrometalurgico para a obtencao de tantalo e niobio
BR9106910A (pt) Processo catalisado aperfeicoado para detergentes de glucamida
BR9602638A (pt) Processo para purificação de melamina
BR9400818A (pt) Processo para a preparação de dialquilpolihidroxiaminas terciárias
BR9601294A (pt) Composto e processo para preparação do mesmo
BR9502950A (pt) Agentes de curtimento processo para sua preparação de método de curtimento
BR9600177A (pt) Processo para a preparação de copolímeros em bloco
BR9408575A (pt) Processo e dispositivo para beneficiamento de minerais úteis
BR9509957A (pt) Processo e dispositivo para o reesmerilhamento de ferramentas ranhuradas
BR9408530A (pt) Intermediário e processo para preparação
ITPN930005A0 (it) Procedimento e macchina perfezionati di presso-piegatura
BR9606199A (pt) Processo para produção de objetos
BR9611599A (pt) Processo para destilar óxido de etileno
BR9401249A (pt) Processo para a obtenção de organoclorossilanos
BR9601278A (pt) Processo para produzir agentes de acilação
BR9405722A (pt) Processo e aparelho para detecçao de passagens anatomicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.